NDC 51326-102 – Replenix Lip Therapy homosalate

Homosalate 150 mg/g; Octinoxate 75 mg/g; Octisalate 50 mg/g; Avobenzone 30 mg/g · Lipstick · Topical

Human Otc Drug

Product NDC51326-102

Product details

Brand name
Replenix Lip Therapy homosalate
Generic name
Homosalate
Labeler
Topiderm, Inc.
Dosage form
Lipstick
Route
Topical
Marketing category
OTC MONOGRAPH DRUG · M020
Marketed since
January 2, 2022
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Replenix Lip Therapy →

Package NDC codes (1)

Package NDCDescriptionSince
51326-102-044 g in 1 BOTTLE (51326-102-04)Jan 2, 2022